Pharma Reaserch (Korea) Market Value
| 214450 Stock | KRW 251,000 500.00 0.20% |
| Symbol | Pharma |
Please note, there is a significant difference between Pharma Reaserch's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharma Reaserch is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharma Reaserch's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pharma Reaserch 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharma Reaserch's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharma Reaserch.
| 01/22/2023 |
| 01/11/2025 |
If you would invest 0.00 in Pharma Reaserch on January 22, 2023 and sell it all today you would earn a total of 0.00 from holding Pharma Reaserch Prod or generate 0.0% return on investment in Pharma Reaserch over 720 days. Pharma Reaserch is related to or competes with Medy Tox, Seegene, ALTEOGEN, and ABL Bio. More
Pharma Reaserch Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharma Reaserch's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharma Reaserch Prod upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.79 | |||
| Information Ratio | 0.0871 | |||
| Maximum Drawdown | 16.81 | |||
| Value At Risk | (5.25) | |||
| Potential Upside | 5.83 |
Pharma Reaserch Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharma Reaserch's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharma Reaserch's standard deviation. In reality, there are many statistical measures that can use Pharma Reaserch historical prices to predict the future Pharma Reaserch's volatility.| Risk Adjusted Performance | 0.0787 | |||
| Jensen Alpha | 0.2848 | |||
| Total Risk Alpha | 0.3326 | |||
| Sortino Ratio | 0.1061 | |||
| Treynor Ratio | 3.4 |
Pharma Reaserch Prod Backtested Returns
Pharma Reaserch appears to be very steady, given 3 months investment horizon. Pharma Reaserch Prod maintains Sharpe Ratio (i.e., Efficiency) of 0.0881, which implies the firm had a 0.0881% return per unit of risk over the last 3 months. We have found thirty technical indicators for Pharma Reaserch Prod, which you can use to evaluate the volatility of the company. Please evaluate Pharma Reaserch's Risk Adjusted Performance of 0.0787, semi deviation of 2.57, and Coefficient Of Variation of 1154.79 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharma Reaserch holds a performance score of 6. The company holds a Beta of 0.0834, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pharma Reaserch's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharma Reaserch is expected to be smaller as well. Please check Pharma Reaserch's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Pharma Reaserch's historical price patterns will revert.
Auto-correlation | 0.47 |
Average predictability
Pharma Reaserch Prod has average predictability. Overlapping area represents the amount of predictability between Pharma Reaserch time series from 22nd of January 2023 to 17th of January 2024 and 17th of January 2024 to 11th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharma Reaserch Prod price movement. The serial correlation of 0.47 indicates that about 47.0% of current Pharma Reaserch price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 2.6 B |
Pharma Reaserch Prod lagged returns against current returns
Autocorrelation, which is Pharma Reaserch stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharma Reaserch's stock expected returns. We can calculate the autocorrelation of Pharma Reaserch returns to help us make a trade decision. For example, suppose you find that Pharma Reaserch has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharma Reaserch regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharma Reaserch stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharma Reaserch stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharma Reaserch stock over time.
Current vs Lagged Prices |
| Timeline |
Pharma Reaserch Lagged Returns
When evaluating Pharma Reaserch's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharma Reaserch stock have on its future price. Pharma Reaserch autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharma Reaserch autocorrelation shows the relationship between Pharma Reaserch stock current value and its past values and can show if there is a momentum factor associated with investing in Pharma Reaserch Prod.
Regressed Prices |
| Timeline |
Pair Trading with Pharma Reaserch
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pharma Reaserch position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Reaserch will appreciate offsetting losses from the drop in the long position's value.Moving against Pharma Stock
| 0.69 | 373220 | LG Energy Solution | PairCorr |
| 0.63 | 051915 | LG Chem | PairCorr |
| 0.56 | 051910 | LG Chemicals | PairCorr |
| 0.44 | 005935 | Samsung Electronics | PairCorr |
| 0.4 | 005387 | Hyundai Motor | PairCorr |
The ability to find closely correlated positions to Pharma Reaserch could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pharma Reaserch when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pharma Reaserch - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pharma Reaserch Prod to buy it.
The correlation of Pharma Reaserch is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pharma Reaserch moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pharma Reaserch Prod moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pharma Reaserch can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Pharma Stock
Pharma Reaserch financial ratios help investors to determine whether Pharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Reaserch security.